EUVIMEDEUVIMED entdecken
Crossref

Metabolite-gated vascular contractility switch: OXGR1 activation mechanism enables agonist therapy for rosacea erythema

Wenqin Xiao, Yan Zhu, Xinjie Tang, Kongkai Zhu, Weifeng Zhang, Mengting Chen, Kui Cai, San Xu, Zheng Wu, Mei Wang, Jiayi Liu, Linglong Long und 18 weitere

Cell · 2026-04 · 189 (7) · 1990-2006.e30

DOI: 10.1016/j.cell.2026.01.036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2026-04. Verfasst von Wenqin Xiao und 29 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Key Laboratory of Aging Biology, Xiangya Hospita…. Hauptthemen laut MEDLINE: Rosacea, Erythema. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 78 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rosacea, an inflammatory skin disorder, poses a dilemma owing to limited effectiveness of treatments for pathological vasodilation-mediated erythema. Here, we identify oxoglutaric acid (α-KG) as a rosacea-associated metabolite elevated in patients and correlated with erythema severity. Exogenous α-KG administration ameliorates rosacea-like manifestations in murine models. Mechanistically, α-KG activates OXGR1, a vascular smooth muscle cell (VSMC)-enriched G protein-coupled receptor (GPCR) to induce Gq signaling and enhance MYL9 phosphorylation, promoting VSMC contraction and limiting vasodilation. Cryo-electron microscopy (cryo-EM) structures of OXGR1-Gq complexes bound to α-KG or itaconate reveal a specific bipartite-acid pocket recognizing its endogenous agonist and an activation mechanism distinct from classical GPCRs. Building on these structures, we developed A-1, a synthetic selective OXGR1 agonist that mitigates erythema and inflammation with efficacy comparable to first-line therapy while offering enhanced safety in rosacea-like models. These findings link a metabolite to vascular dysfunction and nominate OXGR1 agonism for precision treatment of erythema and vascular disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RosaceaErythemaAnimalsHumansMiceFemaleMuscle, Smooth, VascularMaleCryoelectron MicroscopyVasodilationMice, Inbred C57BLReceptors, G-Protein-CoupledDisease Models, AnimalSignal Transduction

Stichwörter der Autor:innen

OXGR1cryo-EMoxoglutaric acidrosaceavasodilation

Substanzen

Receptors, G-Protein-Coupled

Autor:innen und Institutionen

  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China; Hunan Key Laboratory of Aging Biology, Xiangya Hospital, Central South University, Changsha, Hunan, China; National Clinical…
  • Advanced Medical Research Institute, Cheeloo College of Medicine, the Second Qilu Hospital, Shandong University, Jinan, Shandong, China.
  • Key Laboratory Experimental Teratology of the Ministry of Education and Department of Biochemistry and Molecular Biology, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shando…
  • Department of Physiology and Pathophysiology, School of Basic Medical Sciences, State Key Laboratory of Vascular Homeostasis and Remodeling, Peking University, Beijing, China.
  • Hunan Binsis Biotechnology Co., Ltd, Changsha, Hunan, China.
  • Department of Dermatology, Xiangya Hospital, Central South University, Changsha, Hunan, China; The First Hospital of Changsha, Changsha, China; The Affiliated Changsha Hospital of Xiangya School of Medicine, Central Sou…

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Xiao, W., Zhu, Y., Tang, X., Zhu, K., Zhang, W., Chen, M., Cai, K., Xu, S., Wu, Z., Wang, M., Liu, J., Long, L., Tan, Z., Wu, A., Zhou, S., Zhao, Z., Tang, Y., Huang, Y., Wang, B., …, & Li, J. (2026). Metabolite-gated vascular contractility switch: OXGR1 activation mechanism enables agonist therapy for rosacea erythema. Cell, 189(7), 1990-2006.e30. https://doi.org/10.1016/j.cell.2026.01.036

Vancouver

Xiao W, Zhu Y, Tang X, Zhu K, Zhang W, Chen M, et al. Metabolite-gated vascular contractility switch: OXGR1 activation mechanism enables agonist therapy for rosacea erythema. Cell. 2026;189(7):1990-2006.e30. doi:10.1016/j.cell.2026.01.036

BibTeX
@article{Xiao2026,
  author = {Xiao, Wenqin and Zhu, Yan and Tang, Xinjie and Zhu, Kongkai and Zhang, Weifeng and Chen, Mengting and Cai, Kui and Xu, San and Wu, Zheng and Wang, Mei and Liu, Jiayi and Long, Linglong and Tan, Zixin and Wu, Aike and Zhou, Songqi and Zhao, Zhixiang and Tang, Yan and Huang, Yingxue and Wang, Ben and Liu, Fangfen and Wang, Qian and Yang, Fan and Jian, Dan and Shi, Wei and Xie, Hongfu and Chen, Xiang and Guo, Lulu and Deng, Zhili and Sun, Jinpeng and Li, Ji},
  title = {Metabolite-gated vascular contractility switch: OXGR1 activation mechanism enables agonist therapy for rosacea erythema},
  journal = {Cell},
  year = {2026},
  volume = {189},
  number = {7},
  pages = {1990--2006.e30},
  doi = {10.1016/j.cell.2026.01.036}
}
Kostenlos starten →